The US FDA initiated actions to remove concentrated ingestible fluoride prescription drug products for children and set a goal date of Oct. 31 to finish its review, comment period and removal from the market.
- FDA says products were never approved
- HHS to disseminate best practices for dental hygiene in children
- “The best way to prevent cavities in children is by avoiding excessive sugar intake and good dental hygiene, not by altering a child’s microbiome,” FDA Commissioner
Makary said
To view the source of this information, click here
To contact the reporter on this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
